MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0033798
Leewell Pharmaceuticals Private Limited
Leewell Pharmaceuticals Private Limited - trading in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.86 Cr
▲ 94% YoY
Net profit · FY 2025
₹10.95 Lakh
Net margin 5.9%
EBITDA · FY 2025
₹17.88 Lakh
EBITDA margin 9.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10.08 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Leewell Pharmaceuticals Private Limited
Data last updated:
Leewell Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 01 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2016PTC103016. Its GSTIN is 36AADCL0527F1ZV (Telangana). The company holds 9 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santosh Goje and Shivani Mahinderkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.86 Cr, a growth of 94% compared to the previous year. For the same year it recorded a net profit of ₹10.95 Lakh (net margin 5.9%) and EBITDA of ₹17.88 Lakh (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 116% over three years and 75% over five years.
As per MCA filings, the company has open charges of ₹10.08 Lakh on record.
Leewell Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0033798). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100TG2016PTC103016
Registration Number 103016
Incorporation Date 01 February 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0033798
Recognitions & Rankings of Leewell Pharmaceuticals
Contact details
Leewell Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No.8 – 4 – 16/18 Plot No.2 Sri Sai Enclave Old Bowenpally Secunde, Rabad, Hyderabad, Telangana, India – 500015
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Leewell Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Leewell Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Leewell Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Leewell Pharmaceuticals Private Limited, buy the company report.
Financials of Leewell Pharmaceuticals Private Limited
FY 2025 filings availableLeewell Pharmaceuticals Private Limited reported revenue of ₹1.86 Cr (up 94% YoY) for FY 2025.
Revenue · FY 2025
₹1.86 Cr ▲ 94%
Net profit · FY 2025
₹10.95 Lakh margin 5.9%
EBITDA · FY 2025
₹17.88 Lakh margin 9.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 94%
3 years · compounded
▲ 116%
5 years · compounded
▲ 75%
EBITDA CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 157%
5 years · compounded
▲ 132%
Revenue has grown at a compounded annual rate (CAGR) of 75% over five years, including 94% growth in the latest year. EBITDA rose 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.6% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Leewell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Leewell Pharmaceuticals Private Limited
Leewell Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Goje | Director | 01 Feb 2016 | 10 Years 8 Months | Current |
| Shivani Mahinderkar | Director | 19 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Leewell Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nexa Healthcare Private Limited | ₹1.87 Cr (FY 2024) | 3.0% | Meerut, Uttar Pradesh, India | |||
| Ubix Bioscience Private Limited | ₹1.86 Cr (FY 2024) | 24.0% | Uttarakhand, India | |||
| Leewell Pharmaceuticals Private Limitedthis company | ₹1.86 Cr (FY 2025) | ₹10.95 Lakh | 5.9% | 94.0% | Hyderabad, Telangana, India | |
| Uas Pharmaceuticals (India) Private Limited | ₹1.86 Cr (FY 2019) | 0.0% | New Delhi, Delhi, India | |||
| Catholicon Pharmaceuticals Private Limited | ₹1.86 Cr (FY 2025) | -19.0% | Chandigarh, India |
To see the full peer comparison of Leewell Pharmaceuticals Private Limited, buy the company report.
Auditor
Leewell Pharmaceuticals Private Limited is audited by Prabhakar Addagatla & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Prabhakar Addagatla & Associates | FY 2023 | 224160 |
Shareholding
The shareholding of Leewell Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Leewell Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.08 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jan 2023 | 100704553 | Hdfc Bank Limited | ₹10.08 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Leewell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Leewell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Leewell Pharmaceuticals has 9 GST registrations: 9 active. The first 4 active GSTINs are listed below.
Total GSTINs
9
Active
9
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCL0527F1ZV | Telangana | Active | 01 Jul 2017 |
| 07AADCL0527F1ZW | Delhi | Active | 04 Oct 2022 |
| 29AADCL0527F1ZQ | Karnataka | Active | 07 Oct 2022 |
| 27AADCL0527F1ZU | Maharashtra | Active | 14 Oct 2022 |
To see the full GST registrations and return filing status of Leewell Pharmaceuticals Private Limited, buy the company report.
Recent activity
Leewell Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Nyamathabad Laxman ceased to be Director on 19 Jun 2019.
AGM
Leewell Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Leewell Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.08 Lakh with Charge ID 100704553 was registered on 27 Jan 2023.
Ceased
Nyamathabad Laxman ceased to be Director.
Appointed
Shivani Mahinderkar was appointed as Director.
Appointed
Santosh Goje was appointed as Director.
Incorporation
01 Feb 2016
Leewell Pharmaceuticals Private Limited was registered on 01 Feb 2016 with Roc Hyderabad & aged 10 years 8 months as per MCA records.
Frequently asked questions
Leewell Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in wholesale, within the trading industry. It was incorporated on 01 February 2016 (10+ years old) and is registered under CIN U24100TG2016PTC103016.
Leewell Pharmaceuticals has 2 current directors:
- Santosh Goje - Director
- Shivani Mahinderkar - Director
The latest financial statements of Leewell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Leewell Pharmaceuticals is 36AADCL0527F1ZV, registered in Telangana. The company has 9 GST registrations in all, of which 9 are active. Other active GSTINs include 07AADCL0527F1ZW (Delhi), 29AADCL0527F1ZQ (Karnataka), 27AADCL0527F1ZU (Maharashtra).
The CIN (Corporate Identification Number) of Leewell Pharmaceuticals is U24100TG2016PTC103016. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leewell Pharmaceuticals was incorporated on 01 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Leewell Pharmaceuticals by revenue are Nexa Healthcare Private Limited, Ubix Bioscience Private Limited, Uas Pharmaceuticals (India) Private Limited, Catholicon Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Nyamathabad Laxman ceased to be Director on 19 Jun 2019. Shivani Mahinderkar was appointed as Director on 19 Jun 2019. Santosh Goje was appointed as Director on 01 Feb 2016.
Yes, Leewell Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0033798).
The registered office of Leewell Pharmaceuticals is at H No.8 – 4 – 1618 Plot No.2 Sri Sai Enclave Old Bowenpally Secunde, Rabad, Hyderabad, Telangana, India – 500015.
Leewell Pharmaceuticals operates in the trading industry, in the wholesale segment.